Stock Report

All about this stock under one free report Last Updated: 20-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Sarda Proteins Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 519242

₹153.05

up-down-arrow ₹-3.10 (-1.99%)

As on 19-Oct-2026IST

Market cap

info icon

₹137 Cr

Revenue (TTM)

info icon

₹18 Cr

P/E Ratio

info icon

52.2

P/B Ratio

info icon

1.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 1,898.92 18.60 -48.22 44.50 8.58
EBIT -647.40 -560.20 -535.20 -350.85 -515.94
Net Profit 141.98 436.03 749.88 318.19 237.62
EPS 141.97 164.62 282.00 179.90 161.84
Book Value -- -- 0.32 -0.18 3.90
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info -4.58-2.28-13.680.08-11.29
Net Margin info 0.270.6910.950.021.33
Return on equity info -0.183.81--0.321.23
Return on Capital info 0.744.21--0.860.80
Return on Assets info -0.132.655.890.210.85
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
0.86
0.80
0.55
15.81
Peer Median
--
13.66
--
17.67
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
0.32
1.23
-2.08
21.15
Peer Median
8.19
14.72
--
19.14
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

5.89

Higher than Peers by 1.40

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
5.89
0.21
0.85
-1.45
14.72
Peer Median
4.49
4.99
--
7.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-13.68

Lower than Peers by 15.97

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
-13.68
0.08
-11.29
-2.53
2.51
Peer Median
2.29
5.13
--
2.48
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

10.95

Higher than Peers by 9.64

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
10.95
0.02
1.33
-0.55
2.84
Peer Median
1.31
1.61
--
2.12
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
0.00
0.02
1.50
-0.57
2.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-48.22

Lower than Peers by 70.76

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
-48.22
1,766.88
-77.64
-46.14
-5.28
Peer Median
22.54
53.50
--
22.74
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-535.20

Lower than Peers by 558.37

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
-535.20
113.60
0.35
-154.38
1,373.76
Peer Median
23.16
453.13
--
48.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

749.88

Higher than Peers by 721.06

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
749.88
-73.74
158.79
-110.74
1,616.40
Peer Median
28.82
699.41
--
45.95
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

282.00

Higher than Peers by 272.79

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
282.00
-73.78
158.78
-110.74
1,616.34
Peer Median
9.21
368.20
--
100.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
0.32
1.23
-2.05
23.65
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
--
--
--
--
Peer Median
0.03
0.90
--
0.79
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

193.15

Higher than Peers by 191.40

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
193.15
10.51
124.65
98.07
62.92
Peer Median
1.75
1.76
--
1.58
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

193.15

Higher than Peers by 192.07

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
193.15
10.51
124.65
98.07
62.92
Peer Median
1.07
1.04
--
1.18
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
68.33
160.97
498.35
1,774.16
Peer Median
4.45
2.75
--
4.09
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

22.76

Higher than Peers by 17.72

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
22.76
--
--
--
1.93
Peer Median
5.05
6.00
--
6.95
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.41

Lower than Peers by 1.70

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
0.41
10.02
0.57
2.55
5.15
Peer Median
2.10
4.65
--
5.13
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
--
--
--
16.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
3.42
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
-3.42
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

52.19

Higher than Peers by 37.54

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
52.19
4,221.69
478.13
--
20.94
Peer Median
14.66
22.72
--
25.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.58

Lower than Peers by 0.08

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
1.58
13.46
5.82
6.33
4.00
Peer Median
1.66
3.25
--
3.66
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

38.88

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
38.88
1,048.62
482.51
755.15
17.17
Peer Median
--
32.07
--
15.13
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

137

Lower than Peers by 331

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Sarda Proteins
137
22
9
10
6
Peer Median
468
478
--
302
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...